No supplier or customer ties in LNSR's filings yet. The map draws only what companies disclose to the SEC; ties named in other companies' filings join as the graph reads them.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Nothing on the wire mentions LNSR yet. Iris sweeps the public feeds every quarter hour; headlines land here the moment a sweep tags them.
How LNSR has moved on past release days vs its typical ±2.9% day, and how often it closed up. Computed from daily closes — not a forecast.